Artificial intelligence in abdominal aortic aneurysm.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
07 2020
Historique:
received: 14 08 2019
accepted: 07 12 2019
pubmed: 26 2 2020
medline: 1 12 2020
entrez: 26 2 2020
Statut: ppublish

Résumé

Abdominal aortic aneurysm (AAA) is a life-threatening disease, and the only curative treatment relies on open or endovascular repair. The decision to treat relies on the evaluation of the risk of AAA growth and rupture, which can be difficult to assess in practice. Artificial intelligence (AI) has revealed new insights into the management of cardiovascular diseases, but its application in AAA has so far been poorly described. The aim of this review was to summarize the current knowledge on the potential applications of AI in patients with AAA. A comprehensive literature review was performed. The MEDLINE database was searched according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The search strategy used a combination of keywords and included studies using AI in patients with AAA published between May 2019 and January 2000. Two authors independently screened titles and abstracts and performed data extraction. The search of published literature identified 34 studies with distinct methodologies, aims, and study designs. AI was used in patients with AAA to improve image segmentation and for quantitative analysis and characterization of AAA morphology, geometry, and fluid dynamics. AI allowed computation of large data sets to identify patterns that may be predictive of AAA growth and rupture. Several predictive and prognostic programs were also developed to assess patients' postoperative outcomes, including mortality and complications after endovascular aneurysm repair. AI represents a useful tool in the interpretation and analysis of AAA imaging by enabling automatic quantitative measurements and morphologic characterization. It could be used to help surgeons in preoperative planning. AI-driven data management may lead to the development of computational programs for the prediction of AAA evolution and risk of rupture as well as postoperative outcomes. AI could also be used to better evaluate the indications and types of surgical treatment and to plan the postoperative follow-up. AI represents an attractive tool for decision-making and may facilitate development of personalized therapeutic approaches for patients with AAA.

Identifiants

pubmed: 32093909
pii: S0741-5214(19)32911-8
doi: 10.1016/j.jvs.2019.12.026
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

321-333.e1

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Juliette Raffort (J)

Clinical Chemistry Laboratory, University Hospital of Nice, Nice, France; Université Côte d'Azur, CHU, Inserm U1065, C3M, Nice, France.

Cédric Adam (C)

Laboratory of Applied Mathematics and Computer Science (MICS), CentraleSupélec, Université Paris-Saclay, Paris, France.

Marion Carrier (M)

Laboratory of Applied Mathematics and Computer Science (MICS), CentraleSupélec, Université Paris-Saclay, Paris, France.

Ali Ballaith (A)

Department of Vascular Surgery, University Hospital of Nice, Nice, France.

Raphael Coscas (R)

Department of Vascular Surgery, Ambroise Paré University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Boulogne, France; Inserm U1018 Team 5, Versailles-Saint-Quentin et Paris-Saclay Universities, Versailles, France.

Elixène Jean-Baptiste (E)

Université Côte d'Azur, CHU, Inserm U1065, C3M, Nice, France; Department of Vascular Surgery, University Hospital of Nice, Nice, France.

Réda Hassen-Khodja (R)

Université Côte d'Azur, CHU, Inserm U1065, C3M, Nice, France; Department of Vascular Surgery, University Hospital of Nice, Nice, France.

Nabil Chakfé (N)

Department of Vascular Surgery and Kidney Transplantation, University Hospital of Strasbourg, and GEPROVAS, Strasbourg, France.

Fabien Lareyre (F)

Université Côte d'Azur, CHU, Inserm U1065, C3M, Nice, France; Department of Vascular Surgery, University Hospital of Nice, Nice, France. Electronic address: fabien.lareyre@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH